The TP53 tumor suppressor and autophagy in malignant lymphoma

被引:13
|
作者
Xu-Monette, Zijun Y. [1 ]
Young, Ken H. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
autophagy; TP53; survival factor; prognosis; ULK1; EI24; SESN1; NUPR1; ERK; JNK;
D O I
10.4161/auto.19703
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The TP53 (p53) protein is a well-known tumor suppressor that plays a crucial role in maintaining genome stability under various cellular stresses. Loss of TP53 causes lymphomagenesis in mouse models and/or promotes tumor progression. However, the prognostic significance of TP53 has been inconsistent in human cancers including malignant lymphoma. In our recent review of TP53 dysfunction in lymphoid malignancies, we discussed the fact that the TP53 function in autophagy may be one of the important mechanisms responsible for the inconsistency of TP53 prognostic value, in that autophagy can promote survival of lymphoma cells by recycling toxic intracellular materials and inhibiting apoptosis. Here we discuss the biological mechanisms of TP53 functional switches from apoptosis to autophagy, and provide a brief summary of how TP53 regulates autophagy through its transcriptional activity on 14 genes of the TP53 pathway.
引用
收藏
页码:842 / 845
页数:4
相关论文
共 50 条
  • [31] Human p53 tumor suppressor gene (TP53) and schizophrenia: Case-control and family studies
    Ni, XQ
    Trakalo, J
    Valente, J
    Azevedo, MH
    Pato, MT
    Pato, CN
    Kennedy, JL
    NEUROSCIENCE LETTERS, 2005, 388 (03) : 173 - 178
  • [32] Malignant triton tumor in a patient with Li-fraumeni syndrome and a novel TP53 mutation
    Chao, Mwe Mwe
    Levine, John E.
    Ruiz, Robert E.
    Kohlmann, Wendy K.
    Bower, Matthew A.
    Petty, Elizabeth M.
    Mody, Rajen J.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (07) : 1000 - 1004
  • [33] Codon 72 polymorphisms in the tumor suppressor gene TP53 in patients with chronic myelogenous leukemia.
    Bergamaschi, G
    Merante, S
    Galli, A
    Orlandi, E
    Lazzarino, M
    Cazzola, M
    BLOOD, 2003, 102 (11) : 419A - 420A
  • [34] Association of TP53 Polymorphisms on the Risk of Wilms Tumor
    Andrade, R. C.
    Cardoso, L. C. A.
    Ferman, S. E.
    Faria, P. S.
    Seuanez, H. N.
    Achatz, M. I.
    Vargas, F. R.
    PEDIATRIC BLOOD & CANCER, 2014, 61 (03) : 436 - 441
  • [35] TP53 mutations in malignant and premalignant Barrett's esophagus
    Dolan, K
    Walker, SJ
    Gosney, J
    Field, JK
    Sutton, R
    DISEASES OF THE ESOPHAGUS, 2003, 16 (02) : 83 - 89
  • [36] TP53 mutation and survival in aggressive B cell lymphoma
    Zenz, Thorsten
    Kreuz, Markus
    Fuge, Maxi
    Klapper, Wolfram
    Horn, Heike
    Staiger, Annette M.
    Winter, Doris
    Helfrich, Hanne
    Huellein, Jennifer
    Hansmann, Martin-Leo
    Stein, Harald
    Feller, Alfred
    Moeller, Peter
    Schmitz, Norbert
    Truemper, Lorenz
    Loeffler, Markus
    Siebert, Reiner
    Rosenwald, Andreas
    Ott, German
    Pfreundschuh, Michael
    Stilgenbauer, Stephan
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (07) : 1381 - 1388
  • [37] An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
    Jennis, Matthew
    Kung, Che-Pei
    Basu, Subhasree
    Budina-Kolomets, Anna
    Leu, Julia I-Ju
    Khaku, Sakina
    Scott, Jeremy P.
    Cai, Kathy Q.
    Campbell, Michelle R.
    Porter, Devin K.
    Wang, Xuting
    Bell, Douglas A.
    Li, Xiaoxian
    Garlick, David S.
    Liu, Qin
    Hollstein, Monica
    George, Donna L.
    Murphy, Maureen E.
    GENES & DEVELOPMENT, 2016, 30 (08) : 918 - 930
  • [38] A bidirectional crosstalk between autophagy and TP53 determines the pace of aging
    Sica, Valentina
    Kroemer, Guido
    MOLECULAR & CELLULAR ONCOLOGY, 2020, 7 (05)
  • [39] Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
    Tesio, Melania
    HEMASPHERE, 2023, 7 (02):
  • [40] TP53 Action and the Consequences of TP53 Mutation in Acute Myeloid Leukemia
    Lowe, Scott W.
    BLOOD, 2019, 134